Simplexa™ C.difficile Sample Prep Kit MOL5290
Simplexa C.difficile Sample Prep Kit MOL5290 is a clostridium difficile nucleic acid IVD (FDA Class II; FDA product code OZN, C.Difficile Toxin Gene Amplification Assay) made by DiaSorin Molecular LLC, cleared under FDA 510(k) K163085 on 14 Feb 2017 and listed in FDA GUDID since 16 Feb 2017 (UDI-DI 20816101025613), active as of 23 Oct 2026.
Active
510(k)
Valid until
No expiry
FDA recalls
None found
Documents
Trust
Regulatory status
| Region | Authorization | Number | Date | Status |
|---|---|---|---|---|
| United States | GUDID listing | Number20816101025613 | Date16 Feb 2017 | StatusListed |
| United States | FDA 510(k)SESE | NumberK163085 | Date14 Feb 2017 | StatusActive |
Official records
- AccessGUDID record 20816101025613
- FDA 510(k) database K163085
From the FDA record
- MRI safety
- Labeling does not contain MRI Safety Information
- Natural rubber latex
- No latex statement on the label
- Sterility
- Supplied non-sterile
Across registries
- FDA 510(k) K163085 decided 14 Feb 2017 Active
- FDA GUDID UDI-DI 20816101025613 listed 16 Feb 2017 Listed
Timeline
- Cleared FDA 510(k) K163085
- Listed FDA GUDID 20816101025613
Coverage
- Active
- Expiring
- Withdrawn
- Listed
- Not covered
United States — FDA 510(k) Active
Specification
- Trade name
- Simplexa™ C.difficile Sample Prep Kit
- Generic name
- Clostridium difficile nucleic acid IVD, kit, nucleic acid technique (NAT)
- Model / Ref / Catalog
- MOL5290
- Primary DI / UDI-DI
- 20816101025613
- 510(k) Number
- FDA product code
- OZN
- GMDN term
- Clostridium difficile nucleic acid IVD, kit, nucleic acid technique (NAT)
- Device class
- Class II
- Regulation number
- 866.3130
- GUDID distribution status
- In Commercial Distribution